Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
5,564
+27
+0.5% +$4.91K 0.12% 138
2026
Q1
$851K Buy
+5,537
New +$751K 0.1% 171
2022
Q2
Sell
-2,423
Closed -$253K 188
2022
Q1
$253K Sell
2,423
-18
-0.7% -$2.02K 0.04% 158
2021
Q4
$275K Sell
2,441
-2,901
-54% -$312K 0.04% 154
2021
Q3
$621K Buy
5,342
+117
+2% +$14.7K 0.1% 97
2021
Q2
$624K Buy
5,225
+578
+12% +$68.4K 0.1% 97
2021
Q1
$542K Buy
4,647
+301
+7% +$33.4K 0.09% 103
2020
Q4
$510K Buy
4,346
+781
+22% +$79.6K 0.09% 100
2020
Q3
$295K Buy
3,565
+423
+13% +$36.1K 0.07% 127
2020
Q2
$253K Buy
+3,142
New +$245K 0.08% 128

Other funds holding DVA

INVST's DVA Position: Q2 2026 in Review

INVST increased its DaVita (DVA) stake by 0.49% in Q2 2026, buying an estimated $4.91K and bringing the position to 5,564 shares worth $1.24M. The position accounts for 0.12% of the portfolio, ranked #138.

INVST first reported a position in DVA in Q2 2020 and has held it in 10 quarters since. 631 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • INVST held 5,564 shares of DaVita worth $1.24M as of Q2 2026.
  • INVST bought 27 DaVita shares in Q2 2026, an estimated $4.91K.
  • DaVita made up 0.12% of INVST's portfolio in Q2 2026, its #138 holding.
  • INVST first reported a position in DaVita in Q2 2020 and has held it in 10 quarters since.
  • 631 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.